US Broker Ratings

Regeneron Pharmaceuticals (REGN) Stock Analysis: A Biotech Powerhouse with 12.69% Upside Potential

Regeneron Pharmaceuticals, Inc. (REGN), a leading name in the biotechnology sector, continues to capture investor attention with its robust pipeline and strong market presence. Headquartered in Tarrytown, New York, Regeneron..

Amgen Inc. (AMGN) Stock Analysis: Robust Revenue Growth and Strategic Partnerships Propel Investor Interest

Amgen Inc. (AMGN), a titan in the healthcare sector, continues to capture investor attention with its impressive revenue growth and strategic collaborations. As a leading player in the drug manufacturing..

Bristol-Myers Squibb (BMY) Stock Analysis: Navigating Growth with a Solid Dividend Yield

Bristol-Myers Squibb Company (NYSE: BMY) stands as a formidable presence in the healthcare sector, particularly within the drug manufacturing industry. With a market capitalization of $112.5 billion, it is a..

Johnson & Johnson (JNJ) Investor Outlook: Navigating a Solid Healthcare Giant with a Robust 33.62% Return on Equity

Johnson & Johnson (NYSE: JNJ), a stalwart in the healthcare sector, continues to command attention with its formidable market cap of $526.82 billion. Based in New Brunswick, New Jersey, and..

Emergent BioSolutions Inc. (EBS) Stock Analysis: Exploring a 23% Upside Potential and Robust Free Cash Flow

Emergent BioSolutions Inc. (NYSE: EBS) stands as a formidable player in the healthcare sector, specifically within the specialty and generic drug manufacturing industry. Headquartered in Gaithersburg, Maryland, this life sciences..

Personalis, Inc. (PSNL) Stock Analysis: A Promising 14.46% Upside Potential Amid Strategic Collaboration

Personalis, Inc. (NASDAQ: PSNL), a prominent player in the healthcare sector, specializes in diagnostics and research with a focus on advanced cancer genomic tests. As the company stands at a..

Treace Medical Concepts, Inc. (TMCI): Investor Outlook Highlights 83.77% Potential Upside

Investors with an interest in the healthcare sector, particularly in medical devices, should keep a keen eye on Treace Medical Concepts, Inc. (NASDAQ: TMCI). This Florida-based company, with a market..

EyePoint, Inc. (EYPT) Stock Analysis: Exploring the 127.80% Potential Upside in a Challenging Market

Investors with a keen interest in the biotechnology sector might find EyePoint, Inc. (EYPT) an intriguing prospect, particularly given its staggering potential upside of 127.80%. As a player in the..

Myriad Genetics, Inc. (MYGN) Stock Analysis: Uncovering a 36.50% Potential Upside in the Diagnostics Sector

Myriad Genetics, Inc. (NASDAQ: MYGN), a key player in the healthcare sector’s diagnostics and research industry, offers investors a compelling opportunity with a potential upside of 36.50%, according to analyst..

Abivax SA (ABVX) Stock Analysis: A Biotech Gem with 30% Upside Potential

Investors on the hunt for opportunities in the ever-evolving biotechnology sector may find Abivax SA (ABVX) an intriguing prospect. This French biotech company, with a market capitalization of $9.16 billion,..

Sonida Senior Living, Inc. (SNDA) Stock Analysis: Navigating High Growth with Strategic Caution

Sonida Senior Living, Inc. (SNDA), a key player in the medical care facilities industry, continues to draw attention for its robust revenue growth amidst a challenging market landscape. With a..

AxoGen, Inc. (AXGN) Stock Analysis: A Promising 18.51% Potential Upside in the Healthcare Sector

AxoGen, Inc. (NASDAQ: AXGN), a leader in the medical devices industry focused on peripheral nerve regeneration and repair, presents an intriguing opportunity for investors with its significant growth potential. Based..

Humacyte, Inc. (HUMA) Stock Analysis: Exploring a Potential 614% Upside in the Biotech Sector

Humacyte, Inc. (NASDAQ: HUMA), a biotechnology company based in Durham, North Carolina, is making waves in the healthcare sector with its groundbreaking approach to developing implantable bioengineered human tissues. Despite..

MeiraGTx Holdings plc (MGTX) Stock Analysis: A Biotech Gem with a 247.85% Upside Potential

For investors looking to capitalize on the burgeoning biotechnology sector, MeiraGTx Holdings plc (NASDAQ: MGTX) offers a compelling opportunity. This clinical-stage gene therapy company, with a market capitalization of approximately..

Autolus Therapeutics (AUTL): A Biotech with a 545% Potential Upside – Investor Outlook

Autolus Therapeutics plc (NASDAQ: AUTL) is making waves in the biotechnology sector with its ambitious pipeline of T cell therapies aimed at treating cancer and autoimmune diseases. Based in London,..

Kamada Ltd. (KMDA) Stock Analysis: Exploring a 58.15% Upside in the Healthcare Space

Kamada Ltd. (NASDAQ: KMDA), a prominent player in the specialty and generic drug manufacturing sector, has recently garnered attention in the investment community for its robust potential upside. With an..

Sana Biotechnology, Inc. (SANA) Stock Analysis: Exploring a Potential 86.60% Upside in the Biotech Arena

Sana Biotechnology, Inc. (NASDAQ: SANA), a healthcare sector player specializing in biotechnology, has been garnering attention in the investment community. Headquartered in Seattle, Washington, the company is making strides in..

Tectonic Therapeutic, Inc. (TECX) Stock Analysis: Unveiling a Potential 300% Upside in Biotech Investment

Tectonic Therapeutic, Inc. (NASDAQ: TECX), a promising player in the biotech sector, has captured investor attention with its ambitious approach to therapeutic innovation. Headquartered in Watertown, Massachusetts, this biotechnology company..

Orthofix Medical Inc. (OFIX) Stock Analysis: Exploring a 58% Potential Upside in the Medical Device Sector

Orthofix Medical Inc. (NASDAQ: OFIX), a prominent player in the medical device industry, has been capturing investor attention due to its promising potential upside of 58.33%. As a company operating..

Mind Medicine (MNMD) Stock Analysis: A Biotech Bet with 90.86% Potential Upside

As the biopharmaceutical landscape continues to evolve, Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) offers investors a compelling opportunity to engage with the future of brain health treatments. Headquartered in New..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds